Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-07-19 00:00:00 ET · period of report 2022-06-24 · accession 0001493152-22-019821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-19 | 2022-06-24 | IMDX | Carter Jennifer L. | Dir | M - OptEx | $0.00 | +10.0K | 10.0K | New | $0 |
| D | 2022-07-19 | 2022-06-24 | IMDX | Carter Jennifer L. | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-06-24 | M | A | 10,000 | $0.00 | 10,000 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2022-06-24 | M | D | 10,000 | $0.00 | 0 | D | $0.00 · — to — | 10,000 Common Stock | (F1) The Restricted Stock Units vested on June 24, 2022. |